Common use of SCREENING FEE Clause in Contracts

SCREENING FEE. Tularik shall pay NeoGenesis a fee of [*] for each Screening Target screened pursuant to the Screening Program. Such fee shall be payable in two (2) installments - the first installment of [*] at the time such Screening Target is delivered to NeoGenesis and the second installment of [*] within [*] of Completion of Screening; provided, however, that the amount of the second installment shall be reduced for a particular Screening Target by [*] if Completion of Screening does not occur within [*] following delivery of such Screening Target to NeoGenesis. COMPLETION OF SCREENING shall be deemed to occur upon delivery of Selected Screening Compounds for a Screening Target to Tularik (or, if Tularik does not designate any Selected Screening Compound(s) for such Screening Target within [*] of receipt of the Final Target Report for such Screening Target, including any supplement thereto as described in Paragraph 7 of ATTACHMENT A, then at the end of such [*] period). No payment shall be due NeoGenesis under this Section 4.2 with respect to Shared Targets.

Appears in 1 contract

Sources: Confidentiality Agreement (Neogenesis Pharmaceuticals Inc)

SCREENING FEE. Tularik shall pay NeoGenesis a fee of [*] for each Screening Target screened pursuant to the Screening Program. Such fee shall be payable in two (2) installments - the first installment of [*] at the time such Screening Target is delivered to NeoGenesis and the second installment of [*] within [*] ]of Completion of Screening; provided, however, that the amount of the second installment shall be reduced for a particular Screening Target by [*] if Completion of Screening does not occur within [*] following delivery of such Screening Target to NeoGenesis. COMPLETION OF SCREENING shall be deemed to occur upon delivery of Selected Screening Compounds for a Screening Target to Tularik (or, if Tularik does not designate any Selected Screening Compound(s) for such Screening Target within [*] of receipt of the Final Target Report for such Screening Target, including any supplement thereto as described in Paragraph 7 of ATTACHMENT A, then at the end of such [*] period). No payment shall be due NeoGenesis under this Section 4.2 with respect to Shared Targets.

Appears in 1 contract

Sources: Service Agreement (Neogenesis Pharmaceuticals Inc)